U.S. Food and Drug Administration Authorizes Extending the Shelf-life of Janssen


On 28 July 2021, the U.S. Food and Drug Administration (FDA) authorized extension of the shelf-life of Janssen's COVID-19 vaccine, from 4.5 months to 6 months, when stored between 2°C and 8°C. In addition, the FDA indicated that the extension is applicable to lots that may have expired before the issuance of the authorized extension, provided that they have been stored at temperatures of between 2°C and 8°C.

Source: https://www.fda.gov/media/134922/download.

  • Share: